Home / Data / Women's Health Trial Tracker Women's Health Trial Tracker Women's Health Trial Tracker organizes records from ClinicalTrials.gov API v2 into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
Records 5,000
Last changed 10/10/2026
Update schedule 55 1 * * * UTC
Coverage 05/26/2000–10/09/2026 Record Record Date Vuga Group Change Status Recency Days Research Attention Score Mother and Infant Home Visiting Program Evaluation 02/24/2014 INTERVENTIONAL not-comparable 4,611.75 0 The Role of Lifestyle Factors in Breast Cancer-Related Outcomes 03/06/2014 INTERVENTIONAL not-comparable 4,601.75 0 Trial of Superiority of Stereotactic Body Radiation Therapy in Patients With Breast Cancer 03/17/2014 INTERVENTIONAL not-comparable 4,590.75 0 Uterine Leiomyoma Treatment With Radiofrequency Ablation (ULTRA) Registry 04/01/2014 OBSERVATIONAL not-comparable 4,575.75 0 Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer 04/02/2014 INTERVENTIONAL not-comparable 4,574.75 0 Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project 04/03/2014 OBSERVATIONAL not-comparable 4,573.75 0 A Study of Abemaciclib (LY2835219) Combined With Fulvestrant in Women With Hormone Receptor Positive HER2 Negative Breast Cancer 04/08/2014 INTERVENTIONAL not-comparable 4,568.75 0 Cognition in Older Breast Cancer Survivors: Treatment Exposure, APOE and Smoking History 04/24/2014 OBSERVATIONAL not-comparable 4,552.75 0 HOT: HIPEC in Ovarian Cancer as Initial Treatment 04/28/2014 INTERVENTIONAL not-comparable 4,548.75 0 European Active Surveillance Study of LCS12 05/26/2014 OBSERVATIONAL not-comparable 4,520.75 0 Effectiveness of Cervical Screening in HPV Vaccinated Women 05/29/2014 INTERVENTIONAL not-comparable 4,517.75 0 Randomized Controlled Trial Evaluating the Role of Exercise in Women Undergoing Treatment for Breast Cancer 06/12/2014 INTERVENTIONAL not-comparable 4,503.75 0 Sentinel Node Vs Observation After Axillary Ultra-souND 06/19/2014 INTERVENTIONAL not-comparable 4,496.75 0 Incidence of Difficult Airway and Difficult Neuraxial Placement in Obstetric Patients 07/17/2014 OBSERVATIONAL not-comparable 4,468.75 0 Functional Snack Foods With Safflower Oil and Soy in Postmenopausal Women Having Metabolic Syndrome 07/24/2014 INTERVENTIONAL not-comparable 4,461.75 0 Pazopanib Vs. Pazopanib Plus Gemcitabine 07/30/2014 INTERVENTIONAL not-comparable 4,455.75 0 Safety and Immune Response to a Mammaglobin-A DNA Vaccine In Breast Cancer Patients Undergoing Neoadjuvant Endocrine Therapy 07/30/2014 INTERVENTIONAL not-comparable 4,455.75 0 mTORC1/2 Inhibitor AZD2014 or the Oral AKT Inhibitor AZD5363 for Recurrent Endometrial and Ovarian 08/05/2014 INTERVENTIONAL not-comparable 4,449.75 0 Weekly Paclitaxel and Cisplatin to Treat Hormone Receptor Positive and Triple Negative Breast Cancer Patients 08/21/2014 INTERVENTIONAL not-comparable 4,433.75 0 Copper Cu 64-DOTA-Trastuzumab PET in Predicting Response to Treatment With Ado-Trastuzumab Emtansine in Patients With Metastatic HER2 Positive Breast Cancer 08/27/2014 INTERVENTIONAL not-comparable 4,427.75 0 A Study to See Whether Estrogen Can Slow the Growth of Some ER Positive Breast Cancers 09/12/2014 INTERVENTIONAL not-comparable 4,411.75 0 Biomarkerscreening in Cervical Cancer and Its Preinvasive Lesions 09/12/2014 OBSERVATIONAL not-comparable 4,411.75 0 Energy Balance and Breast Cancer Aspects-II 09/16/2014 INTERVENTIONAL not-comparable 4,407.75 0 A Study of Nonsteroidal Aromatase Inhibitors Plus Abemaciclib (LY2835219) in Postmenopausal Women With Breast Cancer 09/23/2014 INTERVENTIONAL not-comparable 4,400.75 0 Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer 10/06/2014 INTERVENTIONAL not-comparable 4,387.75 0 Follow-up of Early Breast Cancer by Dynamic Evaluation of CEA and CA 15.3 Followed by 18FDG-PET 10/10/2014 INTERVENTIONAL not-comparable 4,383.75 0 Prone Partial Breast Irradiation (PBI): a Prospective Randomized Trial 10/28/2014 INTERVENTIONAL not-comparable 4,365.75 0 Comparison of Regimens MPIB, CIPCEA, PCEA 10/30/2014 INTERVENTIONAL not-comparable 4,363.75 0 [18F]ISO-1 Positron Emission Tomography (PET/CT) in Primary Breast Cancer 11/06/2014 INTERVENTIONAL not-comparable 4,356.75 0 Positron Lymphography Via Intracervical 18F-FDG Injection for Pre-surgical Lymphatic Mapping in Stage IB1 Cervical Cancer and High-grade Endometrial Cancer 11/06/2014 INTERVENTIONAL not-comparable 4,356.75 0 DOvEEgene/WISE Genomics: Diagnosing Ovarian and Endometrial Cancer Early Using Genomics 11/11/2014 OBSERVATIONAL not-comparable 4,351.75 0 TARGIT-C(Consolidation) Prospective Phase IV Study of IORT in Patients With Small Breast Cancer 11/14/2014 INTERVENTIONAL not-comparable 4,348.75 0 Chemotherapy-induced Cognitive and Brain Changes in Older Adults With Breast Cancer 11/14/2014 INTERVENTIONAL not-comparable 4,348.75 0 Omega 3 Fatty Acids and ERPR(-)HER2(+/-) Breast Cancer Prevention 11/20/2014 INTERVENTIONAL not-comparable 4,342.75 0 Partial Breast Irradiation Using Interstitial Permanent Palladium-103 Seed Implant 11/21/2014 INTERVENTIONAL not-comparable 4,341.75 0 MRI Assessment of Placental Health 11/21/2014 OBSERVATIONAL not-comparable 4,341.75 0 Development of a Novel Stress Testing Protocol to Define the Relationship Between Coronary Microvascular Dysfunction and Diastology in Women With Angina But No Evidence of Obstructive Coronary Artery Disease 11/26/2014 INTERVENTIONAL not-comparable 4,336.75 0 MRI Background Parenchymal Enhancement as a Risk Factor for Breast Cancer: The IMAGINg and Epidemiology (IMAGINE) Study 11/26/2014 OBSERVATIONAL not-comparable 4,336.75 0 Evaluation of Myocardial Changes During BReast Adenocarcinoma Therapy to Detect Cardiotoxicity Earlier With MRI 12/03/2014 OBSERVATIONAL not-comparable 4,329.75 0 Sickle Cell Hemoglobinopathies and Bone Health 12/03/2014 OBSERVATIONAL not-comparable 4,329.75 0 Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer 12/04/2014 INTERVENTIONAL not-comparable 4,328.75 0 Tamoxifen Citrate or Z-Endoxifen Hydrochloride in Treating Patients With Locally Advanced or Metastatic, Estrogen Receptor-Positive, HER2-Negative Breast Cancer 12/09/2014 INTERVENTIONAL not-comparable 4,323.75 0 Pegylated Liposomal Doxorubicin Hydrochloride and Carboplatin Followed by Surgery and Paclitaxel in Treating Patients With Triple Negative Stage II-III Breast Cancer 12/11/2014 INTERVENTIONAL not-comparable 4,321.75 0 Analysis of Prognostic Cell Signaling Factors in Adolescent Idiopathic Scoliosis 12/12/2014 OBSERVATIONAL not-comparable 4,320.75 0 Impact of Unrestrictive Exercise Following Mid-Urethral Sling Surgery 12/12/2014 INTERVENTIONAL not-comparable 4,320.75 0 Ice Versus EMLA for Pain in Laser Hair Removal 12/17/2014 INTERVENTIONAL not-comparable 4,315.75 0 Study of Placental Function in Healthy and Pathological Pregnancies 12/19/2014 OBSERVATIONAL not-comparable 4,313.75 0 Early Salpingectomy (Tubectomy) With Delayed Oophorectomy in BRCA1/2 Gene Mutation Carriers 12/22/2014 INTERVENTIONAL not-comparable 4,310.75 0 Tc99m Sestamibi Molecular Breast Imaging 12/24/2014 INTERVENTIONAL not-comparable 4,308.75 0 Compass - Randomised Controlled Trial of Primary HPV Testing for Cervical Screening in Australia 12/31/2014 INTERVENTIONAL not-comparable 4,301.75 0
Source U.S. National Library of Medicine, ClinicalTrials.gov API v2 · official record · retrieved 10/10/2026 · upstream last modified 10/10/2026
Licence United States government work; public domain unless the source record says otherwise. Source: U.S. National Library of Medicine
Required notice Study records are informational and do not provide diagnosis, treatment advice, or an assessment of individual risk. What we add We compute Vuga Group, Change Status, Recency Days, Research Attention Score using the documented compute method. · methodology